PD 117519
- CAS No.
- 96392-15-3
- Chemical Name:
- PD 117519
- Synonyms
- CI 947;PD 11751;PD 117519;PD 117519,R;PD 117519 (CI947);PD 117519, 10 mM in DMSO;N-[(R)-Indan-1-yl]adenosine;N-[(1R)-Indan-1-yl]adenosine;(R)-N-(2,3-Dihydro-1H-indenyl)adenosine;PD-117519;PD 117519;PD117519;CI 947;CI947
- CBNumber:
- CB31872452
- Molecular Formula:
- C19H21N5O4
- Molecular Weight:
- 383.4
- MDL Number:
- MFCD00876438
- MOL File:
- 96392-15-3.mol
- MSDS File:
- SDS
PD 117519 price More Price(25)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Cayman Chemical | 28444 | PD 117519 | 96392-15-3 | 5mg | $57 | 2024-03-01 | Buy |
Cayman Chemical | 28444 | PD 117519 | 96392-15-3 | 10mg | $100 | 2024-03-01 | Buy |
Cayman Chemical | 28444 | PD 117519 | 96392-15-3 | 25mg | $208 | 2024-03-01 | Buy |
Cayman Chemical | 28444 | PD 117519 | 96392-15-3 | 50mg | $384 | 2024-03-01 | Buy |
TRC | D449160 | (R)-N-(2,3-Dihydro-1H-indenyl)adenosine | 96392-15-3 | 50mg | $340 | 2021-12-16 | Buy |
PD 117519 Chemical Properties,Uses,Production
Uses
N6-Substituted adenosine receptor agonist; a potential antihypertensive agent.
in vitro
PD 117519 (2-10 mg/kg; oral administration; 16-24 hours; male beagle dogs) treatment produces significant hemodynamic changes at Tmax (4 hours) follows by acute coronary vascular injury that is evident at 16 hours postdosing.Treatment with 2 or 10 mg/kg of PD 117519 produces significant increases in mean heart rate and decreases in mean indirectsystolic blood pressure at time of highest drug exposure, 4 hours postdosing.
in vivo
PD 117519 (2-10 mg/kg; oral administration; 16-24 hours; male beagle dogs) treatment produces significant hemodynamic changes at Tmax (4 hours) follows by acute coronary vascular injury that is evident at 16 hours postdosing.Treatment with 2 or 10 mg/kg of PD 117519 produces significant increases in mean heart rate and decreases in mean indirectsystolic blood pressure at time of highest drug exposure, 4 hours postdosing[3].
Animal Model: | 24 male beagle dogs (8-12 months old)[3] |
Dosage: | 2 mg/kg or 10 mg/kg |
Administration: | Oral administration; 16 hours and 24 hours |
Result: | Increased in mean heart rate and decreased in mean indirectsystolic blood pressure at time of highest drug exposure. Induced acute coronary arteriopathy. The endothelium also appears injured. |
PD 117519 Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
PANNACEAN(HENAN)MEDICINE SCIENCE TECHNOLOGIES LTD | 0371-55159968 18137130222 | haifeng.zhang@pannacean.com | China | 715 | 58 |
Shenzhen Nexconn Pharmatechs Ltd | +86-755-89396905 +86-15013857715 | admin@nexconn.com | China | 10406 | 58 |
BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19552 | 58 |
SHANGHAI T&W PHARMACEUTICAL CO., LTD. | +86-021-61551413 +8618813727289 | contact@trustwe.com | China | 5745 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32376 | 58 |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 | laboratory@coreychem.com | China | 30230 | 58 |
NewCan Biotech Limited | +86-0571-86912261 +8613735419629 | sales@newcanbio.com | China | 9985 | 58 |
LEAP CHEM CO., LTD. | +86-852-30606658 19957148339; | market18@leapchem.com | China | 24727 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354; | support@targetmol.com | United States | 38838 | 58 |
Aladdin Scientific | tp@aladdinsci.com | United States | 57505 | 58 |